Wednesday was a hump day to forget for specialty medical device maker Conformis (NASDAQ: CFMS). Investors weren’t happy with a guidance cut from the company, and expressed their displeasure by trading its shares down by 10.6%.
Wednesday was a hump day to forget for specialty medical device maker Conformis (NASDAQ: CFMS). Investors weren’t happy with a guidance cut from the company, and expressed their displeasure by trading its shares down by 10.6%.